Title : [Treatment of Alzheimer's disease and future approaches] - Forette_2010_Therapie_65_429 |
Author(s) : Forette F , Hauw JJ |
Ref : Therapie , 65 :429 , 2010 |
Abstract : |
PubMedSearch : Forette_2010_Therapie_65_429 |
PubMedID: 21144478 |
Title : [Alzheimer's disease: from brain lesions to new drugs] - Forette_2008_Bull.Acad.Natl.Med_192_363 |
Author(s) : Forette F , Hauw JJ |
Ref : Bull Acad Natl Med , 192 :363 , 2008 |
Abstract : |
PubMedSearch : Forette_2008_Bull.Acad.Natl.Med_192_363 |
PubMedID: 18819689 |
Title : Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications - Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5 |
Author(s) : Fagnani F , Lafuma A , Pechevis M , Rigaud AS , Traykov L , Seux ML , Forette F |
Ref : Dementia & Geriatric Cognitive Disorders , 17 :5 , 2004 |
Abstract : |
PubMedSearch : Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5 |
PubMedID: 14560059 |
Title : Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease - Rigaud_2002_Pharmacogenet_12_415 |
Author(s) : Rigaud AS , Traykov L , Latour F , Couderc R , Moulin F , Forette F |
Ref : Pharmacogenetics , 12 :415 , 2002 |
Abstract : |
PubMedSearch : Rigaud_2002_Pharmacogenet_12_415 |
PubMedID: 12142731 |
Title : The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease - Rigaud_2000_Clin.Chem.Lab.Med_38_205 |
Author(s) : Rigaud AS , Traykov L , Caputo L , Guelfi MC , Latour F , Couderc R , Moulin F , de Rotrou J , Forette F , Boller F |
Ref : Clinical Chemistry & Laboratory Medicine , 38 :205 , 2000 |
Abstract : |
PubMedSearch : Rigaud_2000_Clin.Chem.Lab.Med_38_205 |
PubMedID: 10886308 |
Title : In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects - Traykov_1999_Eur.J.Neurol_6_273 |
Author(s) : Traykov L , Tavitian B , Jobert A , Boller F , Forette F , Crouzel C , Di Giamberardino L , Pappata S |
Ref : Eur Journal of Neurology , 6 :273 , 1999 |
Abstract : |
PubMedSearch : Traykov_1999_Eur.J.Neurol_6_273 |
PubMedID: 10210906 |
Title : A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon) - Forette_1999_Eur.J.Neurol_6_423 |
Author(s) : Forette F , Anand R , Gharabawi G |
Ref : Eur Journal of Neurology , 6 :423 , 1999 |
Abstract : |
PubMedSearch : Forette_1999_Eur.J.Neurol_6_423 |
PubMedID: 10362894 |
Title : First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary - Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266 |
Author(s) : Whitehouse PJ , Winblad B , Shostak D , Bhattacharjya A , Brod M , Brodaty H , Dor A , Feldman H , Forette F , Gauthier S , Hay J , Henke C , Hill S , Mastey V , Neumann P , O'Brien B , Pugner K , Sano M , Sawada T , Stone R , Wimo A |
Ref : Alzheimer Disease & Associated Disorders , 12 :266 , 1998 |
Abstract : |
PubMedSearch : Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266 |
PubMedID: 9876955 |
Title : Clinical trials in cognitive impairment in the elderly - Forette_1992_Aging.(Milano)_4_239 |
Author(s) : Forette F , Panisset M , Boller F |
Ref : Aging (Milano) , 4 :239 , 1992 |
Abstract : |
PubMedSearch : Forette_1992_Aging.(Milano)_4_239 |
PubMedID: 1420408 |
Title : Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results - Boller_1989_Biomed.Pharmacother_43_487 |
Author(s) : Boller F , Forette F |
Ref : Biomed Pharmacother , 43 :487 , 1989 |
Abstract : |
PubMedSearch : Boller_1989_Biomed.Pharmacother_43_487 |
PubMedID: 2684292 |